Article
Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
PloS one - 1 Jan 2017
Inoue Takako, Hmwe Su Su, Shimada Noritomo, Kato Keizo, Ide Tatsuya, Torimura Takuji, Kumada Takashi, Toyoda Hidenori, Tsubota Akihito, Takaguchi Koichi, Wakita Takaji, Tanaka Yasuhito
Abstract excerpt
The aim of this study was to determine the efficacy of two hepatitis C virus (HCV) real-time PCR assays, the COBAS AmpliPrep/COBAS TaqMan HCV test (CAP/CTM) and the Abbott RealTime HCV test (ART), for predicting the clinical outcomes of patients infected with HCV who received telaprevir (TVR)-based triple therapy or daclatasvir/asunaprevir (DCV/ASV) dual therapy. The rapid virological response rates in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
